Ultralife Corporation (ULBI)
Official siteINDUSTRIALS • ELECTRICAL EQUIPMENT & PARTS • NASDAQ
Market Cap: $262.13M
Last updated: Nov 17, 2026 at 11:02 AM ET
Ultralife Corporation (ULBI) Earnings: Report Dates and Results
Ultralife (ULBI) is expected to report earnings on Mar 8, 2027. In the quarter ended Sep 30, 2026, Ultralife reported EPS of $0.14. It beat the EPS estimate in 0 of the 8 most recent quarters that had an estimate.
Earnings
Performance (10Y)
Next Report
ULBI has an expected report date of Mar 8, 2027.
ULBI Earnings Call
The latest ULBI earnings call transcript on file is labeled 2026Q2.
Read the 2026Q2 transcriptEarnings History
Of the 23 quarters below that had an estimate, ULBI beat 6, missed 15 and matched 2. Revenue for the quarter ended Sep 30, 2026 was $48.27M, up 11.3% from $43.37M a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | $0.14 | N/A | N/A | N/A | N/A | +100.0% | N/A | N/A | Nov 5, 2026 | $48.27M |
| Jun 30, 2026 | $0.19 | $0.21 | N/A | -9.52% | Miss | +171.4% | N/A | N/A | Jul 27, 2026 | $47.94M |
| Mar 31, 2026 | -$0.03 | $0.15 | N/A | -120.00% | Miss | -123.1% | N/A | N/A | May 8, 2026 | $47.45M |
| Dec 31, 2025 | -$0.45 | $0.24 | N/A | -285.71% | Miss | -4557.0% | N/A | N/A | Mar 10, 2026 | $48.48M |
| Sep 30, 2025 | $0.07 | $0.21 | N/A | -66.67% | Miss | +600.0% | 1 | 1 up, 0 down | Nov 18, 2025 | $43.37M |
| Jun 30, 2025 | $0.07 | $0.14 | $0.14 - $0.14 | -50.00% | Miss | -61.1% | 1 | 0 up, 0 down | Aug 7, 2025 | $48.56M |
| Mar 31, 2025 | $0.13 | $0.15 | $0.15 - $0.15 | -13.33% | Miss | -38.1% | 1 | 0 up, 1 down | Apr 1, 2025 | $50.75M |
| Dec 31, 2024 | $0.01 | $0.15 | N/A | -93.33% | Miss | N/A | 1 | 0 up, 0 down | Dec 31, 2024 | $43.85M |
| Sep 30, 2024 | $0.01 | $0.21 | N/A | -95.24% | Miss | -90.0% | N/A | 0 up, 0 down | Nov 8, 2024 | $35.69M |
| Jun 30, 2024 | $0.18 | $0.14 | $0.14 - $0.14 | +28.57% | Beat | -14.3% | 1 | 0 up, 0 down | Jul 25, 2024 | $42.98M |
| Mar 31, 2024 | $0.21 | $0.10 | $0.10 - $0.10 | +110.00% | Beat | N/A | 1 | 0 up, 0 down | Apr 25, 2024 | $41.93M |
| Dec 31, 2023 | -$0.01 | $0.09 | N/A | -111.11% | Miss | N/A | N/A | 0 up, 0 down | Feb 15, 2024 | $44.55M |
| Sep 30, 2023 | $0.10 | $0.10 | $0.10 - $0.10 | 0.00% | In line | N/A | 1 | 0 up, 0 down | Oct 26, 2023 | $39.49M |
| Jun 30, 2023 | $0.21 | $0.04 | $0.04 - $0.04 | +425.00% | Beat | +600.0% | 1 | 1 up, 0 down | Jul 27, 2023 | $42.69M |
| Mar 31, 2023 | -$0.02 | -$0.09 | N/A | +77.78% | Beat | -300.0% | 1 | 0 up, 0 down | Apr 27, 2023 | $31.92M |
| Dec 31, 2022 | -$0.01 | $0.09 | N/A | -111.11% | Miss | N/A | N/A | 0 up, 0 down | Mar 2, 2023 | $36.11M |
| Sep 30, 2022 | -$0.01 | $0.06 | N/A | -116.67% | Miss | N/A | 1 | 0 up, 0 down | Oct 27, 2022 | $33.23M |
| Jun 30, 2022 | $0.03 | $0.02 | N/A | +50.00% | Beat | -50.0% | 1 | 0 up, 0 down | Jul 28, 2022 | $32.13M |
| Mar 31, 2022 | $0.01 | -$0.05 | -$0.05 - -$0.05 | +120.00% | Beat | -80.0% | 1 | 0 up, 0 down | Apr 28, 2022 | $30.37M |
| Dec 31, 2021 | -$0.09 | -$0.04 | -$0.04 - -$0.04 | -125.00% | Miss | -169.2% | 1 | 0 up, 0 down | Feb 3, 2022 | $23.76M |
| Sep 30, 2021 | -$0.05 | $0.08 | $0.08 - $0.08 | -162.50% | Miss | -266.7% | 1 | N/A | Oct 28, 2021 | $21.76M |
| Jun 30, 2021 | $0.06 | $0.09 | N/A | -33.33% | Miss | -40.0% | N/A | N/A | Jul 29, 2021 | $26.77M |
| Mar 31, 2021 | $0.05 | $0.06 | N/A | -16.67% | Miss | -28.6% | N/A | N/A | Apr 29, 2021 | $25.97M |
| Dec 31, 2020 | $0.13 | $0.13 | N/A | 0.00% | In line | 0.0% | N/A | N/A | Feb 4, 2021 | $28.98M |
| Sep 30, 2020 | $0.03 | N/A | N/A | N/A | N/A | -57.1% | N/A | N/A | Oct 29, 2020 | $24.36M |
| Jun 30, 2020 | $0.10 | N/A | N/A | N/A | N/A | -44.4% | N/A | N/A | Jul 30, 2020 | $28.56M |
| Mar 31, 2020 | $0.07 | N/A | N/A | N/A | N/A | +133.3% | N/A | N/A | Apr 30, 2020 | $25.81M |
| Dec 31, 2019 | $0.13 | N/A | N/A | N/A | N/A | -89.3% | N/A | N/A | Feb 6, 2020 | $31.02M |
| Sep 30, 2019 | $0.07 | N/A | N/A | N/A | N/A | -22.2% | N/A | N/A | Oct 31, 2019 | $27.49M |
| Jun 30, 2019 | $0.18 | N/A | N/A | N/A | N/A | +80.0% | N/A | N/A | Aug 1, 2019 | $29.40M |
| Mar 31, 2019 | $0.03 | N/A | N/A | N/A | N/A | -76.9% | N/A | N/A | May 2, 2019 | $18.88M |
| Dec 31, 2018 | $1.21 | N/A | N/A | N/A | N/A | +908.3% | N/A | N/A | Feb 7, 2019 | $20.93M |
| Sep 30, 2018 | $0.09 | N/A | N/A | N/A | N/A | +28.6% | N/A | N/A | Nov 1, 2018 | $20.33M |
| Jun 30, 2018 | $0.10 | N/A | N/A | N/A | N/A | +42.9% | N/A | N/A | Aug 2, 2018 | $22.86M |
| Mar 31, 2018 | $0.13 | N/A | N/A | N/A | N/A | +18.2% | N/A | N/A | May 3, 2018 | $23.07M |
| Dec 31, 2017 | $0.12 | N/A | N/A | N/A | N/A | +5.6% | N/A | N/A | Feb 8, 2018 | $22.51M |
| Sep 30, 2017 | $0.07 | N/A | N/A | N/A | N/A | -38.8% | N/A | N/A | Nov 2, 2017 | $21.05M |
| Jun 30, 2017 | $0.07 | N/A | N/A | N/A | N/A | +4.5% | N/A | N/A | Aug 3, 2017 | $19.94M |
| Mar 31, 2017 | $0.11 | N/A | N/A | N/A | N/A | +276.7% | N/A | N/A | May 4, 2017 | $22.04M |
| Dec 31, 2016 | $0.11 | N/A | N/A | N/A | N/A | +482.6% | N/A | N/A | Feb 9, 2017 | $21.63M |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$0.18, after $0.41 the year before. It was $0.32 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$0.18 | -142.9% |
| Dec 31, 2024 | $0.41 | +46.4% |
| Dec 31, 2023 | $0.28 | +1300.0% |
| Dec 31, 2022 | $0.02 | N/A |
| Dec 31, 2021 | -$0.03 | -109.1% |
| Dec 31, 2020 | $0.33 | -19.5% |
| Dec 31, 2019 | $0.41 | -73.2% |
| Dec 31, 2018 | $1.53 | +313.5% |
| Dec 31, 2017 | $0.37 | +14.1% |
| Dec 31, 2016 | $0.32 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q2 for the period ended Jun 30, 2026, runs about 3,100 words across 5 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q2 | Jun 30, 2026 | 3,091 | 5 | |
| 2026Q1 | Mar 31, 2026 | 2,706 | 4 | |
| 2025Q4 | Dec 31, 2025 | 3,403 | 5 | |
| 2025Q3 | Sep 30, 2025 | 2,879 | 4 | |
| 2025Q2 | Jun 30, 2025 | 4,966 | 6 | |
| 2025Q1 | Mar 31, 2025 | 4,173 | 6 | |
| 2024Q3 | Sep 30, 2024 | 4,519 | 7 | |
| 2024Q2 | Jun 30, 2024 | 3,672 | 5 |
2026Q2 Earnings Call
Opening remarks
Jody Burfening Head of Investor Relations Thank you, Lateef, and good morning, everyone. Thank you for joining us for Ultralife Corporation's Earnings Conference Call for the second quarter of fiscal 2026. With us on today's call are Mike Manna, Ultralife's President and CEO, and Phil Fain, Ultralife's Chief Financial Officer. The earnings press release was issued earlier this morning, and if anyone has not yet received a copy, I invite you to visit the company's website, www.ultralifecorp.com, where you'll find the release under Investor News in the Investor Relations section. Before turning the call over to management, I would like to remind everyone that some statements made during this conference call contain forward-looking statements based on current expectations. Actual results could differ materially from those projected as a result of various risks and uncertainties. The potential risks and uncertainties that could cause actual results to differ materially include uncertain global economic conditions, reductions in revenues from key customers, delays or reductions in U.S. and foreign military spending, acceptance of new products on a global basis, and disruptions or delays in supply of raw materials and components due to business conditions, global conflicts, weather, or other factors not under the company's control. The company cautions investors not to place undue reliance on forward-looking statements which reflect the company's analysis only as of today's date. The company undertakes no obligation to publicly update forward-looking statements to reflect subsequent events or circumstances. Further information on these factors and other factors that could affect Ultralife's financial results is included in the company's filings with the Securities and Exchange Commission, including the latest quarterly report on Form 10-Q. In addition, on today's call, management will refer to certain non-GAAP financial measures that management considers to be useful and differ from GAAP. These non-GAAP measures should be considered supplemental to corresponding GAAP figures. With that, I would now like to turn the call over to Mike. Good morning, Mike.
Michael Manna President & CEO Good morning. Welcome to Ultralife's Q2 2026 Earnings Call. Earlier today, we announced Q2 revenue of $47.9 million with operating profit of $3.4 million, which resulted in an EPS of $0.15 per share. We made positive progress on several fronts during the second quarter. We continue to build a strong and growing backlog, supported by an expanding product portfolio as recent product developments transition from development into commercialization. In addition, our new plant leaders in Newark and Raynham are continuing to gain experience and drive operational improvements. Their teams are executing key gross margin initiatives, which have begun to deliver measurable benefits and are expected to contribute further improvements as these efforts gain traction.
Frequently Asked Questions About ULBI
When is Ultralife's next earnings date?
Ultralife's next earnings report is expected for Mar 8, 2027.
How often does ULBI beat earnings estimates?
Ultralife beat the EPS estimate in 0 of the 8 most recent quarters that had an estimate, with an average surprise of -91.73%.
ULBI pages: Overview, Earnings, Financials, Valuation, Competitors, Government Contracts